Sue Fletcher

Citado por

	Total	Desde 2019
Citas	11896	5310
Índice h	58	39
Índice i10	154	117

1400

700

350

1050

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202439 44 66 73 99 153 131 211 290 306 287 381 308 356 385 502 529 1013 530 716 1306 835 1084 950 810 315

Acceso público

Ver todo

58 artículos

9 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Steve WiltonFoundation Chair in Molecular Therapies, Murdoch UniversityDirección de correo verificada de ccg.murdoch.edu.au
Christopher J Mann, PhDMotivate Training LtdDirección de correo verificada de motivate-training.com
Chalermchai MitrpantDepartment of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol UniversityDirección de correo verificada de mahidol.edu
Ianthe PitoutMurdoch UniversityDirección de correo verificada de ccg.murdoch.edu.au
Loren Flynn (Price)Perron Institute for Neurological and Translational Science and Murdoch UniversityDirección de correo verificada de murdoch.edu.au
Francis MastagliaProfessor and Deputy Director, Institute for Immunology and Infectious Diseases, Murdoch University, Western AustraliaDirección de correo verificada de iiid.murdoch.edu.au
Matt BellgardDirector eResearchDirección de correo verificada de qut.edu.au
Nigel LAINGNeurogenetics, University of Western Australia, Harry Perkins Institute of Medical ResearchDirección de correo verificada de uwa.edu.au
Craig S McIntoshCentre for Molecular Medicine and Innovative Therapeutics, Murdoch UniversityDirección de correo verificada de murdoch.edu.au
Sudhir AgrawalARNAY SciencesDirección de correo verificada de arnaysciences.com
jej raskoCentenary InstituteDirección de correo verificada de cenint.org
Kay DaviesProfessor of Genetics University of OxfordDirección de correo verificada de dpag.ox.ac.uk
Kay OhlendieckProfessor Biology, Maynooth UniversityDirección de correo verificada de mu.ie
Arthur BurghesProfessor Molecular and Cellular BiochemistryDirección de correo verificada de osu.edu
André SchultzRespiratory Physician, Perth Children's HospitalDirección de correo verificada de health.wa.gov.au
Roberto BarreroQueensland University of TechnologyDirección de correo verificada de qut.edu.au
Alan BittlesSchool of Medical and Health Sciences, Edith Cowan University and Centre for Comparative GenomicsDirección de correo verificada de ecu.edu.au
Kathryn R NapierLead Data Scientist, COKI Project, Curtin Institute for Data ScienceDirección de correo verificada de curtin.edu.au
Tarun WeeramanthriAdjunct Professor, School of Population Health, University of Western AustraliaDirección de correo verificada de health.wa.gov.au
Haiyan ZhouUniversity College LondonDirección de correo verificada de ucl.ac.uk

Seguir

Sue Fletcher

Professor

Dirección de correo verificada de murdoch.edu.au

RNA therapeutics antisense technology neurodegenerative disease rare diseases


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements LW Barrett, S Fletcher, SD Wilton Cellular and molecular life sciences 69, 3613-3634, 2012	694	2012
ALS genetics, mechanisms, and therapeutics: where are we now? R Mejzini, LL Flynn, IL Pitout, S Fletcher, SD Wilton, PA Akkari Frontiers in neuroscience 13, 497022, 2019	664	2019
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse QL Lu, CJ Mann, F Lou, G Bou-Gharios, GE Morris, S Xue, S Fletcher, ... Nature medicine 9 (8), 1009-1014, 2003	592	2003
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse CJ Mann, K Honeyman, AJ Cheng, T Ly, F Lloyd, S Fletcher, JE Morgan, ... Proceedings of the National Academy of Sciences 98 (1), 42-47, 2001	537	2001
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript SD Wilton, AM Fall, PL Harding, G McClorey, C Coleman, S Fletcher Molecular Therapy 15 (7), 1288-1296, 2007	364	2007
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD G McClorey, HM Moulton, PL Iversen, S Fletcher, SD Wilton Gene therapy 13 (19), 1373-1381, 2006	356	2006
Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides SD Wilton, F Lloyd, K Carville, S Fletcher, K Honeyman, S Agrawal, ... Neuromuscular disorders 9 (5), 330-338, 1999	353	1999
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle BL Gebski, CJ Mann, S Fletcher, SD Wilton Human molecular genetics 12 (15), 1801-1811, 2003	280	2003
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy CJ Mann, K Honeyman, G McClorey, S Fletcher, SD Wilton The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2002	275	2002
Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide S Fletcher, K Honeyman, AM Fall, PL Harding, RD Johnsen, SD Wilton The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006	271	2006
Morpholino oligomer–mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse S Fletcher, K Honeyman, AM Fall, PL Harding, RD Johnsen, JP Steinhaus, ... Molecular Therapy 15 (9), 1587-1592, 2007	234	2007
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping A Goyenvalle, A Babbs, D Powell, R Kole, S Fletcher, SD Wilton, ... Molecular Therapy 18 (1), 198-205, 2010	171	2010
The influence of antisense oligonucleotide length on dystrophin exon skipping PL Harding, AM Fall, K Honeyman, S Fletcher, SD Wilton Molecular Therapy 15 (1), 157-166, 2007	158	2007
Induced dystrophin exon skipping in human muscle explants G Mcclorey, AM Fall, HM Moulton, PL Iversen, JE Rasko, M Ryan, ... Neuromuscular Disorders 16 (9-10), 583-590, 2006	150	2006
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene SJ Errington, CJ Mann, S Fletcher, SD Wilton The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003	148	2003
Antisense oligonucleotides for inducing exon skipping and methods of use thereof SD Wilton, S Fletcher, G McClorey US Patent 7,807,816, 2010	135	2010
Antisense oligonucleotides for inducing exon skipping and methods of use thereof SD Wilton, S Fletcher, G McClorey US Patent 8,232,384, 2012	127	2012
Cell-penetrating peptide–morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo HM Moulton, S Fletcher, BW Neuman, G McClorey, DA Stein, S Abes, ... Biochemical Society Transactions 35 (4), 826-828, 2007	125	2007
Antisense oligonucleotides for inducing exon skipping and methods of use thereof SD Wilton, S Fletcher, G McClorey US Patent 7,960,541, 2011	121	2011
Proteomic profiling of antisense‐induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm P Doran, SD Wilton, S Fletcher, K Ohlendieck Proteomics 9 (3), 671-685, 2009	118	2009

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores